Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

PCOS increases sexual pain distress in infertile women.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Finasteride may cause long-lasting sexual side effects.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Finasteride doesn't reduce sexual function in people with hair loss.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.